Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

35.29
Delayed Data
As of Mar 05
 -0.13 / -0.37%
Today’s Change
31.22
Today|||52-Week Range
52.58
-30.60%
Year-to-Date
No recent news for Enanta Pharmaceuticals Inc.

Today’s Trading

Previous close35.42
Today’s open35.27
Day’s range-- - --
Volume192,643
Average volume (3 months)400,950
Market cap$661.6M
Dividend yield--
Data as of 03/05/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+266.45%
Earnings growth (next 5 years)--
Revenue growth (last year)+48.94%
P/E ratio8.3
Price/Sales19.55
Price/Book4.43

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.33+2.23%
TGTXTG Therapeutics Inc+0.74+4.98%
AMPHAmphastar Pharmaceut...+0.01+0.07%
PETXAratana Therapeutics...+0.33+1.68%
Data as of 03/05/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$1.69
Annual revenue (last year)$47.7M
Annual profit (last year)$34.4M
Net profit margin72.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
Chief Financial Officer &
Senior VP-Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account